When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. White dot syndromes - Wikipedia

    en.wikipedia.org/wiki/White_dot_syndromes

    Gass described the 'AZOOR complex' which consists of multiple evanescent white dot syndrome, nultifocal choroiditis, punctate inner choroiditis, acute idiopathic blind spot enlargement, acute macular neuroretinopathy, acute annular outer retinopathy, and acute zonal occult outer retinopathy. He suggested these diseases represent one disease due ...

  3. Treatment and management of COVID-19 - Wikipedia

    en.wikipedia.org/wiki/Treatment_and_management...

    This registry based, multi-center, multi-country data provide provisional support for the use of ECMO for COVID-19 associated acute hypoxemic respiratory failure. Given that this is a complex technology that can be resource intense, guidelines exist for the use of ECMO during the COVID-19 pandemic.

  4. Executive Order 13997 - Wikipedia

    en.wikipedia.org/wiki/Executive_Order_13997

    Executive Order 13997, officially titled Improving and Expanding Access to Care and Treatments for COVID-19, was signed on January 21, 2021, and was the thirteenth executive order signed by U.S. President Joe Biden. The order worked to ameliorate and increase access to COVID-19 care and treatment. [1]

  5. Acute posterior multifocal placoid pigment epitheliopathy

    en.wikipedia.org/wiki/Acute_posterior_multifocal...

    Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is an acquired inflammatory uveitis that belongs to the heterogenous group of white dot syndromes in which light-coloured (yellowish-white) lesions begin to form in the macular area of the retina.

  6. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

    www.aol.com/fda-approves-biosimilars-macular...

    Macular degeneration treatment is safe and effective. The FDA approval was based on a review of scientific evidence showing that both drugs are “highly similar” to Regeneron Pharmaceuticals’ ...

  7. Nirmatrelvir/ritonavir - Wikipedia

    en.wikipedia.org/wiki/Nirmatrelvir/ritonavir

    In November 2023, the FDA revised the EUA for nirmatrelvir/ritonavir to authorize EUA- or NDA-labeled nirmatrelvir/ritonavir for the treatment of mild-to-moderate COVID‑19 in people aged twelve years of age and older weighing at least 40 kilograms (88 lb), who are at high risk for progression to severe COVID‑19, including hospitalization. [18]

  8. Chloroquine and hydroxychloroquine during the COVID-19 ...

    en.wikipedia.org/wiki/Chloroquine_and_hydroxych...

    A World Health Organization infographic that states that hydroxychloroquine does not prevent illness or death from COVID-19. Chloroquine and hydroxychloroquine are anti-malarial medications also used against some auto-immune diseases. [1] Chloroquine, along with hydroxychloroquine, was an early experimental treatment for COVID-19. [2]

  9. Maculopathy - Wikipedia

    en.wikipedia.org/wiki/Maculopathy

    Age-Related Macular Degeneration is a degenerative maculopathy associated with progressive sight loss. It is characterised by changes in pigmentation in the Retinal Pigment Epithelium, the appearance of drusen on the retina of the eye and choroidal neovascularization. AMD has two forms; 'dry' or atrophic/non-exudative AMD, and 'wet' or ...